GI-101

GI-101 · GI Innovation, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GI-101, covering 2026-03-17 to 2026-03-17. Get the full timeline:

Most recent: Clinical Trial Update: GI-101/GI-101A as a Single Agent or in Combination With Pembrolizumab or Lenvatinib in Advanced Solid Tumors [Phase 1, Phase 2]

See pricing